NEW YORK, September 23, 2020 -- Arsenal Capital Partners ("Arsenal"), a private equity firm that specializes in investments in healthcare and industrial companies, today announced its partnership with Dr. Richard Eglen as a Senior Advisor to its healthcare team. Dr.
Acquisition reflects ambition to build an enterprise designed to enable healthcare clients to maximize the value of their products and accelerate patient access to medical and technological advances
NEW YORK, July 13, 2020 - Arsenal Capital Partners (“Arsenal”), a leading private equity firm that invests in specialty industrials and healthcare companies, today announced several significant human capital updates.
Pharma Value Demonstration, a portfolio company of Arsenal, reached an agreement with the board of Cello Health plc on the terms of a recommended cash offer for the entire issued, and to be issued, share capital of Cello.
Arsenal Capital Partners, a leading private equity firm investing in healthcare and specialty industrials companies, announced today the acquisition of BresMed Health Solutions, a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry.
